4//SEC Filing
Zojwalla Naseem 4
Accession 0001415889-23-016321
CIK 0001750284other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 5:55 PM ET
Size
6.9 KB
Accession
0001415889-23-016321
Insider Transaction Report
Form 4
Zojwalla Naseem
CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2023-12-11$7.02/sh+2,900$20,358→ 46,664 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-11−2,900→ 234,000 totalExercise: $7.02Exp: 2032-01-31→ Common Stock (2,900 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vested on January 31, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
Documents
Issuer
Olema Pharmaceuticals, Inc.
CIK 0001750284
Entity typeother
Related Parties
1- filerCIK 0001905871
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 5:55 PM ET
- Size
- 6.9 KB